Found 4 matching trials
GV 1001 Immunotherapy in Patients With Non-small Cell Lung Cancer (NSCLC)
NATo examine the safety and efficacy of telomerase peptide vaccination ( stim...
Location
Rikshospitalet - Radiumhospitalet HF
Study of the Telomerase Vaccine GV1001 to Treat Patients With Inoperable Stage III Non-small Cell Lung Cancer
PHASE3The purpose of this study is to evaluate survival in inoperable stage III N...
Location
Multiple Locations
Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
PHASE3RATIONALE: Drugs used in chemotherapy, such as gemcitabine and capecitabine...
Location
North Devon District Hospital
Trial With Telomerase Peptide Vaccine In Combination With Temozolomide in Patients With Advanced Malignant Melanoma
PHASE1Primary objective: Determination of safety and tolerability of GV1001 admin...
Location
Oslo University Hospital